MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/infdis/jiaf274

Медицинская библиотека · The Journal of infectious diseases · 2025

Efficacy of RTS,S/AS01E Only Seen in Baseline Parasitemic and Not Baseline Aparasitemic Plasmodium falciparum-Exposed, Drug-Treated Kenyan Adults.

Copeland Nathanial K, Otieno Lucas, Otieno June Doryne, Otieno Solomon, Chira Salome, Ivinson Karen, Onyango Irene, Wasuna Ruth, Akala Hoseah, Onditi Amos, Sifuna Peter, Andagalu Ben, Oyugi Roselyne, Omondi Mary, Amoit Stellah, Locke Emily, Gregory Scott, Bergmann-Leitner Elke S, Pindolia Hema, Raine Mike, Gast Chris, Mercer Laina D, Aponte John J, Lievens Marc, Ockenhouse Christian F, Lee Cynthia K

СтатьяРандомизированное исследованиеКлиническое исследование II фазыПеревод в очереди

Аннотация

BACKGROUND

RTS,S/AS01 vaccine efficacy (VE) was previously shown as lower in African adults than in malaria-naive US adults, potentially due to concurrent Plasmodium falciparum infections. We investigated whether treatment of infection prior to vaccination would lead to improved VE and immunogenicity.

METHODS

A phase 2b study in Kenyan adults evaluated the efficacy of RTS,S/AS01E in conjunction with antimalarial chemopreventive drugs. Participants, grouped by baseline presence or absence of P. falciparum infections, were randomized to receive RTS,S/AS01E or rabies vaccine. Four groups received antimalarial drugs prior to immunization and were followed for 6 months to assess P. falciparum infection. We included an additional group not treated with antimalarial drugs for immunological assessment.

RESULTS

VE (RTS,S/AS01E vs rabies vaccine) was 34.8% (95% confidence interval [CI], 8.9% to 53.4%) and -24.0% (95% CI, -97% to 22.4%) in baseline P. falciparum-positive and P. falciparum-negative participants, respectively. In RTS,S/AS01E recipients, there were no statistical differences in anticircumsporozoite (anti-CS) antibody titers in baseline P. falciparum-positive or P. falciparum-negative participants, or in susceptibility to infection during the postvaccination follow-up period. Drug treatment did not improve anti-CS antibody titers.

CONCLUSIONS

Treating P. falciparum infections during vaccination does not result in increased VE. Anti-CS antibody responses to vaccination do not differ with baseline P. falciparum infection status, drug treatment, or susceptibility to P. falciparum infections.

CLINICAL TRIALS REGISTRATION: NCT04661579; PACTR202006896481432.

Для цитирования: Copeland Nathanial K, Otieno Lucas, Otieno June Doryne, Otieno Solomon, Chira Salome, Ivinson Karen, Onyango Irene, Wasuna Ruth, Akala Hoseah, Onditi Amos, Sifuna Peter, Andagalu Ben, Oyugi Roselyne, Omondi Mary, Amoit Stellah, Locke Emily, Gregory Scott, Bergmann-Leitner Elke S, Pindolia Hema, Raine Mike, Gast Chris, Mercer Laina D, Aponte John J, Lievens Marc, Ockenhouse Christian F, Lee Cynthia K. Efficacy of RTS,S/AS01E Only Seen in Baseline Parasitemic and Not Baseline Aparasitemic Plasmodium falciparum-Exposed, Drug-Treated Kenyan Adults.. The Journal of infectious diseases. 2025. DOI: 10.1093/infdis/jiaf274.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.